Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
基本信息
- 批准号:9768889
- 负责人:
- 金额:$ 46.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-11 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAutoantigensAutoimmune DiseasesAutoimmunityB-LymphocytesBloodCellsClinicColorectal CancerCuesCutaneousCutaneous MelanomaDataDendritic CellsDendritic cell activationDepositionDetectionDevelopmentEmigrantFeedbackGene ExpressionGenesGeneticGlomerulonephritisGoalsGrowthHematopoieticHomeostasisHumanIFNGR1 geneImmuneImmune ToleranceImmune systemImmunityImmunologic SurveillanceImmunologyImmunotherapyImpairmentIn SituIn VitroInflammationInflammatoryInterferon Type IILeadLungLymphoid TissueMalignant NeoplasmsMalignant neoplasm of lungModalityModelingMusPDCD1LG1 genePathway interactionsPatientsPeripheralPopulationPropertyRegulationRegulatory T-LymphocyteReportingRoleScienceScreening for Skin CancerSeedsSelf ToleranceSentinelSkinSkin CancerSurveysT-LymphocyteTestingTherapeutic InterventionTissuesTranscriptTravelTumor EscapeVaccinesadaptive immunitybasecell motilityconditioningdiphtheria toxin receptorimprovedin vivoin vivo Modellymph nodesmacrophagemonocytenovelperipheral toleranceprogramsskin disordertherapeutic targettooltraffickingtumortumor progression
项目摘要
Project Summary/Abstract
The immune system surveys the skin and other barrier tissues such as lung and gut, but
mechanisms for failed immunity in the periphery that lead to cancer or autoimmune diseases
are unknown. The dendritic cell (DC) is a specialized immune sentinel that directs T cells to
tolerance or immunity. DC comprise a rich network in skin consisting of several different
populations, but are understudied, leaving a major gap in therapeutic intervention. We have
identified distinct properties for DC in skin that relay information by migrating out to the draining
lymph node (LN). We find during inflammation skin migratory DC may direct T cells to tolerance
by unknown mechanisms, counter-regulating and controlling immunity. These cells are uniquely
genetically programed in humans and in mouse to dampen immunity with a high expression of
shared tolerance genes, including some genes such as PD-L1 that have been successfully
targeted in the clinic for peripheral tissue cancers including melanoma skin cancer, colorectal
cancer and lung cancer. We hypothesize homeostatic programming of skin DC leads to failed
immune priming leading to impaired early detection of skin cancers. We find these pathways are
of great importance as therapeutic targets to promote self-tolerance (such as during
autoimmune disease) or to block tolerance (to improve immunity during cancer). Because these
mechanisms are distinct they can be combined with current modalities for patients in
immunotherapy of skin cancer, vaccine science, and inflammatory skin disease. In 2 discrete
aims, this application will address programmatic conditioning of skin DCs and the unique cellular
mechanisms by which they promote immune tolerance in both mice and humans, examining
consequences during immune priming and early skin cancer growth.
项目总结/摘要
免疫系统检查皮肤和其他屏障组织,如肺和肠,但
导致癌症或自身免疫性疾病的外周免疫失败的机制
是未知的。树突状细胞(DC)是一种专门的免疫哨兵,它指导T细胞
容忍或豁免。DC在皮肤中包含一个丰富的网络,
这是一个非常重要的问题,因为它在人口中,但研究不足,在治疗干预方面留下了一个重大空白。我们有
确定皮肤中DC的不同属性,通过迁移到引流区来传递信息
淋巴结(LN)。我们发现在炎症过程中,皮肤迁移性DC可能指导T细胞耐受
通过未知的机制,反调节和控制免疫力。这些细胞是独一无二的
在人类和小鼠中进行基因编程,以高表达
共享的耐受基因,包括一些基因,如PD-L1,已经成功地
在临床上靶向治疗外周组织癌症,包括黑色素瘤皮肤癌、结肠直肠癌
癌症和肺癌。我们假设皮肤DC的稳态编程导致失败的
免疫引发导致皮肤癌的早期检测受损。我们发现这些通路
作为促进自身耐受性的治疗靶点是非常重要的(例如在
自身免疫性疾病)或阻断耐受性(以提高癌症期间的免疫力)。因为这些
机制是不同的,它们可以与当前的模式相结合,
皮肤癌免疫治疗、疫苗科学和炎症性皮肤病。在2个离散
目的,该应用程序将解决皮肤DC的程序性调节和独特的细胞调节。
它们促进小鼠和人类免疫耐受的机制,
在免疫引发和早期皮肤癌生长过程中的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niroshana Anandasabapathy其他文献
Niroshana Anandasabapathy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niroshana Anandasabapathy', 18)}}的其他基金
High-parametric flow cytometry cell sorter for human immunology studies.
用于人类免疫学研究的高参数流式细胞仪细胞分选仪。
- 批准号:
10632888 - 财政年份:2023
- 资助金额:
$ 46.05万 - 项目类别:
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
探究 DC 对组织的独特适应,以促进屏障免疫和耐受性
- 批准号:
10378337 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
探究 DC 对组织的独特适应,以促进屏障免疫和耐受性
- 批准号:
10579963 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9684364 - 财政年份:2018
- 资助金额:
$ 46.05万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
10004498 - 财政年份:2018
- 资助金额:
$ 46.05万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9397655 - 财政年份:2016
- 资助金额:
$ 46.05万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9258870 - 财政年份:2016
- 资助金额:
$ 46.05万 - 项目类别:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
通过皮肤树突状细胞实现稳态和耐受的外周机制
- 批准号:
9353720 - 财政年份:2016
- 资助金额:
$ 46.05万 - 项目类别:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
Flt3L——增强树突状细胞免疫佐剂的临床应用
- 批准号:
8609183 - 财政年份:2012
- 资助金额:
$ 46.05万 - 项目类别:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
Flt3L——增强树突状细胞免疫佐剂的临床应用
- 批准号:
9096028 - 财政年份:2012
- 资助金额:
$ 46.05万 - 项目类别:
相似海外基金
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10764143 - 财政年份:2023
- 资助金额:
$ 46.05万 - 项目类别:
Study of identification for autoantigens in a mouse model of pituitary dysfunction induced by CTLA-4 or PD-1 blockade
CTLA-4或PD-1阻断诱导的垂体功能障碍小鼠模型中自身抗原的鉴定研究
- 批准号:
22K08648 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10545634 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
identification of autoantigens of autoimmune pancreatitis
自身免疫性胰腺炎自身抗原的鉴定
- 批准号:
21H02901 - 财政年份:2021
- 资助金额:
$ 46.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic Basis of Variable Expression of Glycan Xeno-Autoantigens by Cattle
牛聚糖异种自身抗原变异表达的遗传基础
- 批准号:
DP200103734 - 财政年份:2020
- 资助金额:
$ 46.05万 - 项目类别:
Discovery Projects
The study to identify novel pathogenesis and autoantigens in patients with membranous nephropathy
确定膜性肾病患者新发病机制和自身抗原的研究
- 批准号:
19K08694 - 财政年份:2019
- 资助金额:
$ 46.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10356015 - 财政年份:2019
- 资助金额:
$ 46.05万 - 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10093988 - 财政年份:2019
- 资助金额:
$ 46.05万 - 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10560561 - 财政年份:2019
- 资助金额:
$ 46.05万 - 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
- 批准号:
19H03686 - 财政年份:2019
- 资助金额:
$ 46.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)